Experimental STAR-T cell therapy aims to tame multiple sclerosis
Disease control
Not yet recruiting
This early-stage trial will test the safety of a new immune cell therapy called universal STAR-T cells in 24 adults with multiple sclerosis (MS) who have no other treatment options. The therapy involves infusing specially engineered cells that may help control the disease. The st…
Phase: PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC